Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Comment by TheBearInTheWoodson Mar 31, 2021 8:18pm
182 Views
Post# 32919982

RE:RE:RE:( CANADA ) investments of more than $1 billion

RE:RE:RE:( CANADA ) investments of more than $1 billion

 

You're being a poor sport if you blame provincial jurisdiction, I would imagine all those listed below have patents though, don't blame Trudeau, blame yourself 

Abcellera Biologics Inc. BC $175,631,000 $287,353,000 2020-05-03 Therapeutics and bio-manufacturing
Variation Biotechnologies Inc. (VBI) ON $55,976,000 $74,636,000 2020-08-05 Vaccines
Precision NanoSystems Inc. BC $18,203,000 $24,271,000 2020-10-23 Vaccines
Medicago Inc. QC $173,000,000 $428,002,000 2020-10-23 Vaccines and Bio-manufacturing
Arch BioPartners ON $6,715,000 $8,953,000 2020-12-15 Therapeutics
Edesa Biotech Research, Inc. ON $14,053,000 $18,738,000 2021-02-02 Therapeutics
Precision NanoSystems Inc. BC $25,112,000 $50,224,000 2021-02-02 Bio-manufacturing
KABS Laboratories Inc. QC $54,209,000 $84,843,000 2021-03-16 Bio-manufacturing
Novocol Pharmaceutical of Canada ON $32,716,000 $72,632,000 2021-03-16 Bio-manufacturing
Immune Biosolutions Inc.  QC $13,442,000 $18,670,000 2021-03-16 Therapeutics

<< Previous
Bullboard Posts
Next >>